Beta Blocker News and Research

RSS
Beta-adrenergic receptor blocking agents (beta-blockers) are drugs with multiple actions on the heart. Blockade of beta-1 receptors results in slowing of heart rate, reduction in myocardial contractility, and lowering of systemic blood pressure. In the context of acute myocardial infarction (AMI), which represents a state of reduced oxygen supply to the affected portion of the heart, these effects may be beneficial as they result in reduced myocardial workload and oxygen demand. Furthermore, beta-blockers may reduce the risk of ventricular arrhythmias, which are an important cause of death following AMI.
Anti-anxiety medication dampens helping behavior in rats

Anti-anxiety medication dampens helping behavior in rats

Inhibiting adrenaline receptors reduces breast cancer brain metastases

Inhibiting adrenaline receptors reduces breast cancer brain metastases

Entresto drug shows added benefit in symptomatic chronic heart failure

Entresto drug shows added benefit in symptomatic chronic heart failure

Intravenous beta blockers offer no clinical benefit to patients with STEMI

Intravenous beta blockers offer no clinical benefit to patients with STEMI

Beta blockers may improve effectiveness of triple negative breast cancer treatments

Beta blockers may improve effectiveness of triple negative breast cancer treatments

Tackling insulin resistance may reduce recurrence after stroke

Tackling insulin resistance may reduce recurrence after stroke

Findings may lead to new treatment strategy for phobia

Findings may lead to new treatment strategy for phobia

Dr. Sidney Goldstein to receive Heart Failure Society of America's Lifetime Achievement Award

Dr. Sidney Goldstein to receive Heart Failure Society of America's Lifetime Achievement Award

Scientists develop a way to stop pharmaceuticals from contaminating drinking water

Scientists develop a way to stop pharmaceuticals from contaminating drinking water

Treatment with life-saving medications increases in IHD but levels still suboptimal

Treatment with life-saving medications increases in IHD but levels still suboptimal

Study shows beta blockers may benefit women with ovarian cancer

Study shows beta blockers may benefit women with ovarian cancer

Beta-blockers improve overall survival among epithelial ovarian cancer patients

Beta-blockers improve overall survival among epithelial ovarian cancer patients

Endocrinology Network offers up-to-date coverage of SGLT2 inhibitors

Endocrinology Network offers up-to-date coverage of SGLT2 inhibitors

Study indicates major added benefit of propranolol in some children with haemangioma

Study indicates major added benefit of propranolol in some children with haemangioma

Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

New treatment for Marfan syndrome works as well as beta blockers

New treatment for Marfan syndrome works as well as beta blockers

Investigational treatment shows promise against Marfan syndrome

Investigational treatment shows promise against Marfan syndrome

Studies evaluate traditional management of heart attack patients after discharge from hospital

Studies evaluate traditional management of heart attack patients after discharge from hospital

QT Medical partners with LA BioMed to identify infants at risk of long QT syndrome

QT Medical partners with LA BioMed to identify infants at risk of long QT syndrome

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness